These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2683937)

  • 1. Effect of varying drop size on the efficacy and safety of a topical beta blocker.
    Charap AD; Shin DH; Petursson G; Cinotti D; Wortham E; Brown RH; Silverstone DE; Atkins JM; Eto CY; Lue JC
    Ann Ophthalmol; 1989 Sep; 21(9):351-7. PubMed ID: 2683937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
    Stryz JR; Merté HJ
    Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
    Krieglstein GK; Novack GD; Voepel E; Schwarzbach G; Lange U; Schunck KP; Lue JC; Glavinos EP
    Br J Ophthalmol; 1987 Apr; 71(4):250-3. PubMed ID: 2883990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term ocular hypotensive effect of levobunolol: results of a one-year study.
    Ober M; Scharrer A; David R; Biedner BZ; Novack GD; Lue JC; Robins DS; Duzman E
    Br J Ophthalmol; 1985 Aug; 69(8):593-9. PubMed ID: 3893528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
    Călugăru M
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment.
    Rakofsky SI; Melamed S; Cohen JS; Slight JR; Spaeth G; Lewis RA; Zbrowski-Gutman L; Eto CY; Lue JC; Novack GD
    Ophthalmology; 1989 Jan; 96(1):8-11. PubMed ID: 2645553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC; Leland TM; Cate EA; Stewart JA
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the clinical study of a new adrenergic beta blocker levobunolol hydrochloride in healthy subjects and in patients with glaucoma].
    Egorov EA; Shmeleva IA
    Vestn Oftalmol; 1992; 108(3):24-5. PubMed ID: 1481323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levobunolol compared with timolol for the control of elevated intraocular pressure.
    Geyer O; Lazar M; Novack GD; Lue JC; Duzman E
    Ann Ophthalmol; 1986 Oct; 18(10):289-90, 292. PubMed ID: 3535611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.